Author

Joseph Shatzel

Oregon Health & Science University - Cited by 2,493 - Hematology

Biography

Joseph Shatzel is an innovative bioscience researcher and passionate clinical professional with an affinity for hematology and oncology. He has extended valuable service for many years and has been a recipient of many awards and grants.
Title
Cited by
Year
Thrombosis and bleeding in extracorporeal membrane oxygenation (ECMO) without anticoagulation: a systematic review
SR Olson, CR Murphree, D Zonies, AD Meyer, OJT McCarty, ...ASAIO journal (American Society for Artificial Internal Organs: 1992) 67 (3 …, 2021202
82
2021
North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension
JR Boike, BG Thornburg, SK Asrani, MB Fallon, BE Fortune, MJ Izzy, ...Clinical Gastroenterology and Hepatology 20 (8), 1636-1662. e36, 2022202
65
2022
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial
CU Lorentz, EI Tucker, NG Verbout, JJ Shatzel, SR Olson, BD Markway, ...Blood, The Journal of the American Society of Hematology 138 (22), 2173-2184, 2021202
37
2021
CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real‐world practice
MT West, CE Smith, A Kaempf, TCL Kohs, R Amirsoltani, J Ribkoff, ...European journal of haematology 106 (5), 634-642, 2021202
29
2021
Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function
TJ Zheng, ER Lofurno, AR Melrose, HHS Lakshmanan, J Pang, ...American Journal of Physiology-Cell Physiology 320 (5), C902-C915, 202
21
2021
Analysis of adverse events and intravenous iron infusion formulations in adults with and without prior infusion reactions
AH Arastu, BK Elstrott, KL Martens, JL Cohen, MH Oakes, ZT Rub, ...JAMA network open 5 (3), e224488-e224488, 2022202
14
2022
Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus
R Silasi, RS Keshari, G Regmi, C Lupu, C Georgescu, JH Simmons, ...Blood, The Journal of the American Society of Hematology 138 (2), 178-189, 2021202
14
2021
Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function
I Parra-Izquierdo, AR Melrose, J Pang, HHS Lakshmanan, SE Reitsma, ...Platelets 33 (3), 404-415, 2022202
13
2022
Development of coagulation factor XII antibodies for inhibiting vascular device-related thrombosis
TCL Kohs, CU Lorentz, J Johnson, C Puy, SR Olson, JJ Shatzel, D Gailani, ...Cellular and Molecular Bioengineering 14, 161-175, 2021202
10
2021
The hemostatic and thrombotic complications of liver disease
HS McMurry, J Jou, J ShatzelEuropean journal of haematology 7 (4), 383-392, 2021202
10
2021
The incidence, complications, and treatment of iron deficiency in pregnancy
AE Benson, JJ Shatzel, KS Ryan, MA Hedges, K Martens, JE Aslan, JO LoEuropean Journal of Haematology 10 (6), 633-642, 2022202
9
2022
Assessing the risk of thromboembolism in cancer patients receiving immunotherapy
A Goel, A Khorana, T Kartika, S Gowda, DL Tao, R Thawani, JJ ShatzelEuropean journal of haematology 10 (4), 271-277, 2022202
8
2022
Hormonal therapies and venous thrombosis: Considerations for prevention and management
C LaVasseur, S Neukam, T Kartika, BS Bannow, J Shatzel, ...Research and Practice in Thrombosis and Haemostasis 6 (6), e1263, 2022202
7
2022
The role of oral iron in the treatment of adults with iron deficiency
JO Lo, AE Benson, KL Martens, MA Hedges, HS McMurry, T DeLoughery, ...European Journal of Haematology 110 (2), 123-130, 2023202
7
2023
Role of platelets in regulating activated coagulation factor XI activity
SE Reitsma, J Pang, V Raghunathan, JJ Shatzel, CU Lorentz, EI Tucker, ...American Journal of Physiology-Cell Physiology 320 (3), C35-C374, 2021202
6
2021
Travel-associated venous thromboembolism
IMK Johnson, J Shatzel, S Olson, T Kohl, A Hamilton, TG DeLougheryWilderness & environmental medicine 33 (2), 19-178, 2022202
6
2022
Severe thrombocytopenia in adults undergoing extracorporeal membrane oxygenation is predictive of thrombosis
TCL Kohs, P Liu, V Raghunathan, R Amirsoltani, M Oakes, OJT McCarty, ...Platelets 33 (4), 570-57, 2022202
6
2022
Heparin resistance is common in patients undergoing extracorporeal membrane oxygenation but is not associated with worse clinical outcomes
V Raghunathan, P Liu, TCL Kohs, R Amirsoltani, M Oakes, OJT McCarty, ...ASAIO journal (American Society for Artificial Internal Organs: 1992) 7 (8 …, 2021202
6
2021
Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer
NW Watson, SA Wander, JJ Shatzel, H Al‐SamkariCancer 128 (17), 3224-3232, 2022202
6
2022